Splenic Mastocytosis: Report of Two Cases and Detection of the Transforming Somatic C-KIT Mutation D816V

References

• Lennert, K. and Parwaresch, M.R. (1979) "Mast cells and mast cell neoplasia: a review", Histopathology, 3, 349–365.
   PubMed Web of Science ®Google Scholar
• Parwaresch, M.R., Horny, H.-P. and Lennert, K. (1985) "Tissue mast cells in health and disease", Pathology, Research and Practice, 179, 439–361.
   PubMed Web of Science ®Google Scholar
• Metcalfe, D.D. (1991) "Classification and diagnosis of mastocytosis: current status", Journal of Investigative Dermatology, 96, 2S —4S.
   Google Scholar
• Valent, P. (1996) "Biology, classification and treatment of human mastocytosis", Wiener Klinische Wochenschrift, 108, 385–397.
   PubMed Web of Science ®Google Scholar
• Caplan, R.M. (1963) "The natural course of urticaria pigmentosa", Archives of Dermatology, 87, 146 — 149.
   Google Scholar
• Travis, W.D., Li, C.V., Bergstralh, E.J., Yam, L.T. and Swee, R.G. (1988) "Systemic mast cell disease. Analysis of 58 cases and literature review", Medicine, 67, 345–368.
   PubMed Web of Science ®Google Scholar
• Horan, R.F. and Austen, K.F. (1991) "Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital", Journal of Investigative Dermatology, 96, 5S — 13S.
   Google Scholar
• Akin, C., Kirshenbaum, AS., Semere, T., Worobec, AS., Scott, L.M. and Metcalfe, D.D. (2000) "Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis", Experimental Hematology, 28, 140 — 147.
   Google Scholar
• Longley, B.J., Tyrrell, L., Lu, S.Z., Ma, Y.S., Langley, K., Ding, T.G., et al. (1996) "Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm", Nature Genetics, 12, 312–314.
   PubMed Web of Science ®Google Scholar
• Longley B.J., Metcalfe D.D., Tharp M., Wang, X., Tyrrell, L., Lu, S.Z., et al. (1999) "Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis", Proceedings of the National Academy of Sciences of the United States of America, 96, 1609 — 1614.
   Web of Science ®Google Scholar
• Nagata, H., Worobec, AS., Oh, C.K., Chowdhury, BA., Tannen-baum, S., Suzuki, Y., et al. (1995) "Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocy-tosis with an associated hematologic disorder", Proceedings of the National Academy of Sciences of the United States of America, 92, 10560 — 10564.
   Google Scholar
• Horny, H.-P., Parwaresch, M.R. and Lennert, K. (1985) "Bone marrow findings in systemic mastocytosis", Human Pathology, 16, 808 — 814.
   Google Scholar
• Horny, H.-P., Sillaber, C., Menke, D., Kaiserling, E., Wehrmann, M., Stehberger, B., et al. (1998) "Diagnostic value of immunostain-ing for tryptase in patients with mastocytosis", American Journal of Surgical Pathology, 22, 1132–1140.
   PubMed Web of Science ®Google Scholar
• Horny, H.-P. and Valent, P. (2001) "Diagnosis of mastocytosis: General histopathological aspects, morphological criteria, and immunohistochemical findings", Leukemia Research, 25, 543–551.
   PubMed Web of Science ®Google Scholar
• Sperr, W.R., Escribano, L., Jordan, J.H., Schernthaner, G.H., Kundi, M., Horny, R-P., et al. (2001) "Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis", Leukemia Research, 25, 529 — 536.
   Google Scholar
• Schwartz, LB., Sakai, K., Bradford, T.R., Ren, S., Zweiman, B., Worobec, AS., et al. (1995) "The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis", Journal of Clinical Investogations, 96, 2702–2710.
   Google Scholar
• Schwartz, LB., Metcalfe, D.D., Miller, J.S., Earl, H. and Sullivan, T. (1987) "Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis", New England Journal of Medicine, 316, 1622–1626.
   Web of Science ®Google Scholar
• Escribano, L., Orfao, A., Diaz-Agustin, B., Villarrubia, J., Cervero, C., Lopez, A., et al. (1998) "Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications", Blood, 91, 2731 —2736.
   Google Scholar
• Valent, P., Horny, R-P., Escribano, L., Longley, B.J., Li, C.Y., Schwartz, LB., et al. (2001) "Diagnostic criteria and classification of mastocytosis: a consensus proposal", Leukemia Research, 25, 603— 625.
   Google Scholar
• Valent, P., Horny, H.-P., Li, C.Y., Longley, J.B., Metcalfe, D.D., Parwaresch, R.M., et al. (2001) Mastocytosis (Mast cell disease). In World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues, edited by E.S. Jaffe, N.L. Harris, H. Stein and J.W. Vardiman. IARC Press, Lyon, France, Vol 1. Pp 291–302.
   Google Scholar
• Valent, P., Akin, C., Sperr, W.R., Horny, H.-P. and Metcalfe, D.D. (2002) "Smouldering mastocytosis: a new type of systemic mastocytosis with slow progression", International Archives of Allergy and Immunology, 127, 137 — 139.
   Google Scholar
• Sperr, W.R., Jordan, J.H., Fiegl, M., Escribano, L., Bellas, C., Dirnhofer, S., et al. (2002) "Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease", International Archives of Allergy and Immunology, 128, 136 — 141.
   Google Scholar
• Hsu, S.M., Raine, L. and Fanger, H. (1981) "Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) proce-dures", Journal of Histochemistry and Cytochemistry, 29, 577 — 580.
   Google Scholar
• Sotlar, K., Escribano, L., Landt, O., Mohrle, S., Herrero, S., Torrelo, A., et al. (2003) "One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes", American Journal of Pathology, 162, 737–746.
   Google Scholar
• Fritsche-Polanz, R., Jordan, J.H., Feix, A, Sperr, W.R., Sunder-Plassmannm, G., Valent, P., et al. (2001) "Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocy-tosis and cases of systemic mastocytosis", British Journal of Haematology, 113, 357 — 364.
   Google Scholar
• Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., et al. (1993) "Identification of mutations in the coding sequence of the protooncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of the c-kit product", Journal of Clinical Investigation, 92, 1736–1744.
   Web of Science ®Google Scholar
• Ende, N. and Cherniss, E.I. (1958) "Splenic mastocytosis", Blood, 13, 631–633.
   PubMed Web of Science ®Google Scholar
• Jordan, J.H., Walchshofer, S., Jurecka, W., Mosberger, I., Sperr, W.R., Wolff, K., et al. (2001) "Phenotypic properties of mast cells in patients with systemic mastocytosis: evidence for abnormal expres-sion of CD2, CD117/c-kit, and bc1-xL", Human Pathology, 32, 545–552.
   Google Scholar
• Denburg, J.A., Telizyn, S., Ahlstedt, S., Olafsson, J.H., Roupe, G. and Bienenstock, J. (1986) "Basophil/mast cell precursors in mast cell proliferative disorders", Clinical and Investigative Medicine, 9, 21–25.
   Google Scholar
• Rottem, M., Okada, T., Goff, J.P. and Metcalfe, D.D. (1994) "Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34 + /Fc epsilon RI-cell population", Blood, 84, 2489–2496.
   PubMed Web of Science ®Google Scholar
• Friend, D.S., Gurish, M.F., Austen, K.F., Hunt, J. and Stevens, R.L. (2000) "Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection", Journal of Immunology, 165, 344— 352.
   Google Scholar
• Lawrence, J.B., Friedman, B.S., Travis, W.D., Chinchilli, V.M., Metcalfe, D.D. and Gralnick, H.R. (1991) "Hematologic manifesta-tions of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis", American Journal of Medicine, 91, 612–624.
   Google Scholar
• Travis, W.D., Li, C.Y., Yam, L.T., Bergstralh, E.J. and Swee, R.G. (1988) "Significance of systemic mast cell disease with associated hematologic disorders", Cancer, 62, 965–972.
   Google Scholar
• Horny, H.-P., Ruck, M., Wehrmann, M. and Kaiserling, E. (1990) "Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders", British Journal of Haematology, 76, 186— 193.
   Google Scholar
• Sperr, W.R., Horny, H.-P., Lechner, K. and Valent, P. (2000) "Clinical and biologic diversity of leukemias occuring in patients with mastocytosis", Leukemia and Lymphoma, 37, 473 —486.
   Google Scholar
• Wimazal, F., Walchshofer, S., Baghestanian, M., Chott, A., Sperr, W.R., Kopp, C., et al. (1998) "Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis", Wiener Klinische Wochenschrist, 110, 79–88.
   Google Scholar